|
US4440859A
(en)
|
1977-05-27 |
1984-04-03 |
The Regents Of The University Of California |
Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms
|
|
US4704362A
(en)
|
1977-11-08 |
1987-11-03 |
Genentech, Inc. |
Recombinant cloning vehicle microbial polypeptide expression
|
|
DK171727B1
(da)
|
1978-12-22 |
1997-04-14 |
Biogen Inc |
Rekombinante hepatitis B virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenspecifikke polypeptider, DNA-sekvenser kodende for HBV-antigenspecifikke polypeptider, metoder til påvisning af hepatitis B virus-antistoffer, metoder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider og midler til påvisning af HBV-infektion
|
|
US4530901A
(en)
|
1980-01-08 |
1985-07-23 |
Biogen N.V. |
Recombinant DNA molecules and their use in producing human interferon-like polypeptides
|
|
US4342566A
(en)
|
1980-02-22 |
1982-08-03 |
Scripps Clinic & Research Foundation |
Solid phase anti-C3 assay for detection of immune complexes
|
|
US4678751A
(en)
|
1981-09-25 |
1987-07-07 |
Genentech, Inc. |
Hybrid human leukocyte interferons
|
|
US4766075A
(en)
|
1982-07-14 |
1988-08-23 |
Genentech, Inc. |
Human tissue plasminogen activator
|
|
US4582800A
(en)
|
1982-07-12 |
1986-04-15 |
Hoffmann-La Roche Inc. |
Novel vectors and method for controlling interferon expression
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4757006A
(en)
|
1983-10-28 |
1988-07-12 |
Genetics Institute, Inc. |
Human factor VIII:C gene and recombinant methods for production
|
|
US4677063A
(en)
|
1985-05-02 |
1987-06-30 |
Cetus Corporation |
Human tumor necrosis factor
|
|
US4810648A
(en)
|
1986-01-08 |
1989-03-07 |
Rhone Poulenc Agrochimie |
Haloarylnitrile degrading gene, its use, and cells containing the gene
|
|
US4897445A
(en)
|
1986-06-27 |
1990-01-30 |
The Administrators Of The Tulane Educational Fund |
Method for synthesizing a peptide containing a non-peptide bond
|
|
DE69420137T2
(de)
|
1993-06-03 |
1999-12-23 |
Therapeutic Antibodies, Inc. |
Herstellung von antikörperfragmenten
|
|
AUPM322393A0
(en)
|
1993-12-24 |
1994-01-27 |
Austin Research Institute, The |
Mucin carbohydrate compounds and their use in immunotherapy
|
|
US5977300A
(en)
|
1994-06-03 |
1999-11-02 |
Ludwig Institute Of Cancer Research |
Isolated nonapeptide which bind to HLA-B44 molecules and the uses thereof
|
|
CA2243235C
(en)
|
1996-01-17 |
2010-08-10 |
Imperial College Innovations Limited |
Immunotherapy using cytotoxic t lymphocytes (ctl)
|
|
US5849589A
(en)
|
1996-03-11 |
1998-12-15 |
Duke University |
Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
AU2001229681A1
(en)
|
2000-01-20 |
2001-07-31 |
Ludwig Institute For Cancer Research |
Mage antigenic peptides which bind hla-b35 and hla-b44
|
|
US20040191260A1
(en)
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
|
IL151860A0
(en)
|
2000-03-27 |
2003-04-10 |
Technion Res & Dev Foundation |
Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same
|
|
AU7524601A
(en)
|
2000-06-05 |
2001-12-17 |
Sunol Molecular Corp |
T cell receptor fusions and conjugates and methods of use thereof
|
|
US20030171275A1
(en)
|
2000-12-20 |
2003-09-11 |
Baughn Mariah R. |
Transporters and ion channels
|
|
US20030087245A1
(en)
|
2001-01-24 |
2003-05-08 |
Eos Biotechnology, Inc. |
Uses of PBH1 in the diagnosis and therapeutic treatment of prostate cancer
|
|
AU2002322280A1
(en)
|
2001-06-21 |
2003-01-21 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
|
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
|
EP1485075A4
(en)
|
2002-02-20 |
2006-04-26 |
Dyax Corp |
MHC-PEPTIDE COMPLEX BINDING LIGANDS
|
|
US7311914B2
(en)
|
2002-08-13 |
2007-12-25 |
Ludwig Institute For Cancer Research |
MAGE-A4 antigenic peptides and uses thereof
|
|
NZ539225A
(en)
|
2002-10-09 |
2006-09-29 |
Avidex Ltd |
Single chain recombinant T cell receptors
|
|
AU2003276403B2
(en)
|
2002-11-09 |
2010-04-15 |
Adaptimmune Limited |
T cell receptor display
|
|
GB0304068D0
(en)
|
2003-02-22 |
2003-03-26 |
Avidex Ltd |
Substances
|
|
US7348007B2
(en)
|
2004-02-09 |
2008-03-25 |
Ludwig Institute For Cancer Research |
Mage C2 antigenic peptides and uses thereof
|
|
US7883858B2
(en)
|
2005-01-27 |
2011-02-08 |
Institute For Systems Biology |
Methods for identifying and monitoring drug side effects
|
|
EP1806358B1
(en)
|
2005-09-05 |
2010-03-17 |
Immatics Biotechnologies GmbH |
Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
|
|
WO2007053570A2
(en)
|
2005-10-31 |
2007-05-10 |
Janssen Pharmaceutica N.V. |
A polypeptide complex of trpm8 and calmodulin and its uses thereof
|
|
US20090263574A1
(en)
|
2008-04-21 |
2009-10-22 |
Quinn Daniel E |
Method of restoring an article
|
|
US20110318380A1
(en)
|
2008-10-01 |
2011-12-29 |
Dako Denmark A/S |
MHC Multimers in Cancer Vaccines and Immune Monitoring
|
|
US9840695B2
(en)
|
2009-04-28 |
2017-12-12 |
Agriculture Victoria Services Pty Ltd |
Plant technology
|
|
GB201006360D0
(en)
|
2010-04-16 |
2010-06-02 |
Immatics Biotechnologies Gmbh |
Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
|
|
KR102095670B1
(ko)
|
2010-05-14 |
2020-03-31 |
더 제너럴 하스피톨 코포레이션 |
종양 특이적 신생항원을 확인하는 조성물 및 방법
|
|
WO2012056407A1
(en)
|
2010-10-26 |
2012-05-03 |
Technion Research & Development Foundation Ltd. |
Antibodies which bind soluble t-cell receptor ligands
|
|
WO2012094744A1
(en)
|
2011-01-11 |
2012-07-19 |
University Health Network |
Prognostic signature for oral squamous cell carcinoma
|
|
WO2013057586A1
(en)
|
2011-10-19 |
2013-04-25 |
Oslo Universitetssykehus Hf |
Compositions and methods for producing soluble t - cell receptors
|
|
EP2917388B1
(en)
|
2012-11-08 |
2016-10-05 |
Roche Diagnostics GmbH |
Nucleic acids encoding chimeric polypeptides for library screening
|
|
EP2808392A1
(en)
|
2013-05-28 |
2014-12-03 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Aptamers and use of the aptamers in the diagnosis and treatment of cancer
|
|
GB201319446D0
(en)
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
|
EP4636401A2
(en)
|
2014-12-19 |
2025-10-22 |
The Broad Institute, Inc. |
Methods for profiling the t-cell-receptor repertoire
|
|
GB201505305D0
(en)
*
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
US11130798B2
(en)
|
2015-05-19 |
2021-09-28 |
La Jolla Institute For Allergy And Immunology |
Human APOB100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosis
|
|
GB201513921D0
(en)
|
2015-08-05 |
2015-09-23 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
|
|
GB201520541D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
|
IL265479B
(en)
*
|
2016-09-21 |
2022-09-01 |
Amal Therapeutics Sa |
A fusion containing a cell-penetrating peptide, a multiple epitope, and a peptide tlr agonist for cancer therapy
|
|
AU2018226566B2
(en)
*
|
2017-03-03 |
2025-01-23 |
Treos Bio Limited |
Population-based immunogenic peptide identification platform
|
|
US11427614B2
(en)
|
2017-04-10 |
2022-08-30 |
Immatics Biotechnologies Gmbh |
Peptides and combination thereof for use in the immunotherapy against cancers
|
|
WO2018189152A2
(en)
|
2017-04-10 |
2018-10-18 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers
|
|
WO2019007974A1
(en)
|
2017-07-07 |
2019-01-10 |
Immatics Biotechnologies Gmbh |
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NSCLC, CPPC AND OTHER CANCERS
|
|
US11945850B2
(en)
|
2018-09-17 |
2024-04-02 |
Immatics Biotechnologies Gmbh |
B*44 restricted peptides for use in immunotherapy against cancers and related methods
|